# A Study of LY3540378 in Healthy Participants

> **NCT04768855** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 134 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3540378
- **DRUG:** Placebo
- **DRUG:** LY3540378

## Key facts

- **NCT ID:** NCT04768855
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-17
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2022-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04768855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04768855, "A Study of LY3540378 in Healthy Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04768855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*